Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022
Kévin Bihan, Lorène Lipszyc, F. Lemaı̂tre, Anne Dautriche, Sophie Fédrizzi, Marina Atzenhoffer, Aurélie Vitores, A Page, Bénédicte Lebrun‐Vignes
Topics & Concepts
PharmacovigilanceRitonavirMedicinePharmacologyVirologyAdverse effectHuman immunodeficiency virus (HIV)Antiretroviral therapyViral loadPharmacovigilance and Adverse Drug ReactionsCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research